Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Armen Shanafelt currently holds 150,000 shares of Surface Oncology, Inc. (SURF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Armen Shanafelt has been a net buyer of SURF stock. They have purchased $15.3M and sold $0 worth of shares.
Armen Shanafelt's most recent insider trade was on Dec 13, 2021, when they purchased 14,685 shares at $3.65 per share.
Armen Shanafelt serves as Executive at Surface Oncology, Inc. (SURF). They have executed 12 insider transactions totaling $15.3M over their tenure at the company.
Armen Shanafelt holds the position of Executive at Surface Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Armen Shanafelt has shown a buying trading pattern, with $15.3M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Armen Shanafelt was on Aug 16, 2016, when they purchased $7.0M worth of PTGX shares. This transaction involved 583,333 shares at $12.00 per share.
Armen Shanafelt currently owns 150,000 shares of Surface Oncology, Inc. (SURF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Armen Shanafelt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Armen Shanafelt has 12 Form 4 filings on record as an insider at Surface Oncology, Inc..
Set alerts for Armen Shanafelt and 40,000+ other insiders.